Long-acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population-based cohort study.

Stéphanie LaroseChristopher FilliterRobert W PlattOriana H Y YuKristian B Filion

Published in: Diabetes, obesity & metabolism (2023)

Compared with NPH insulin, long-acting insulin analogues were not associated with the risk of incident DR among patients with type 2 diabetes. This finding provides important reassurance regarding the safety of long-acting insulin analogues with respect to incident DR.

Keyphrases

type diabetes
diabetic retinopathy
glycemic control
molecular docking
cardiovascular disease
optical coherence tomography
structure activity relationship
adipose tissue